Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Meanwhile, AKRO is a 2.5B$ company.

<< Previous

Bullboard Posts

Next >>

Comment by PWIB123on Dec 16, 2022 6:07pm

115 Views

Post# 35177011

RE:RE:RE:Meanwhile, AKRO is a 2.5B$ company.

Trogarzon - You went from someone who may have needed to vent for a couple days to an absolutely irritating, petulant and abusive poster. Free speech doesn't protect one's credibility, and you've lost any and all credibility. I don't even want to read these posts anymore, because I have to filter through your barrage of meaningless words. Just stop it. If you think THTX is reading your comments, their not. Save the space for wise words that we do want them to read. Someone already pointed it out, but any new investor coming to read your junk isn't going to be super impressed with the prospects. If you do indeed want the stock to rise, use your words more judiciously.